전장 유전체 시퀀싱 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 및 서비스별, 유형별, 워크플로우별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product & Service, By Type, By Workflow, By Application, By End User, By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,169,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,541,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 10,968,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

전장 유전체 시퀀싱(WGS) 세계 시장은 2024년 20억 5,000만 달러로 평가되며, 예측 기간 동안 12.15%의 CAGR로 성장하여 2030년까지 40억 9,000만 달러에 달할 것으로 예상됩니다.

WGS는 생물의 전체 유전자 설계도를 분석할 수 있는 능력으로 유전체학, 맞춤의료, 진단, 연구 분야에서 기반이 되는 도구가 되고 있습니다. 시퀀싱 기술의 지속적인 발전, 처리량 증가, 비용 감소로 인해 헬스케어, 농업, 법의학 등 다양한 분야에서 WGS의 채택이 확대되고 있습니다. 임상 진단에서 WGS의 통합이 진행되고, 유전체학에 대한 공공 및 민간 투자가 확대되면서 시장 모멘텀을 더욱 촉진하고 있습니다. 높은 비용, 데이터 관리의 복잡성, 규제 준수 등의 과제가 남아있지만, AI와 머신러닝의 통합과 새로운 애플리케이션의 출현으로 시장의 성장 궤도는 가속화될 것으로 예상됩니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	20억 5,000만 달러
시장 규모 : 2030년	40억 9,000만 달러
CAGR : 2025-2030년	12.15%
급성장 부문	대규모 전장 유전체 시퀀싱
최대 시장	북미

주요 시장 촉진요인

유전성 질환의 유병률 증가

주요 시장 과제

전장 유전체 시퀀싱의 높은 비용

주요 시장 동향

유전체 데이터 분석에 인공지능과 머신러닝을 통합하는 방법

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품 및 서비스별(기기, 소모품, 서비스)
  • 유형별(대규모 전장 유전체 시퀀싱, 소규모 전장 유전체 시퀀싱)
  • 워크플로우별(프리 시퀀싱, 시퀀싱, 데이터 분석)
  • 용도별(인간 전장 유전체 시퀀싱, 식물 전장 유전체 시퀀싱, 동물 전장 유전체 시퀀싱, 미생물 전장 유전체 시퀀싱)
  • 최종사용자별(학술·연구기관, 병원·진료소, 제약·바이오테크놀러지 기업, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 전장 유전체 시퀀싱 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병

제13장 세계의 전장 유전체 시퀀싱 시장 : SWOT 분석

제14장 경쟁 구도

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc..

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The Global Whole Genome Sequencing (WGS) Market was valued at USD 2.05 billion in 2024 and is expected to reach USD 4.09 billion by 2030, growing at a CAGR of 12.15% during the forecast period. WGS has become a foundational tool across genomics, personalized medicine, diagnostics, and research, owing to its ability to analyze an organism's entire genetic blueprint. Continuous advancements in sequencing technology, increased throughput, and declining costs are expanding WGS adoption across diverse sectors including healthcare, agriculture, and forensics. The growing integration of WGS in clinical diagnostics and expanding public and private investments in genomics are further driving market momentum. While challenges such as high costs, data management complexity, and regulatory compliance remain, the integration of AI and machine learning, along with the emergence of new applications, is expected to accelerate the market's growth trajectory.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 2.05 Billion
Market Size 2030	USD 4.09 Billion
CAGR 2025-2030	12.15%
Fastest Growing Segment	Large Whole Genome Sequencing
Largest Market	North America

Key Market Drivers

Increasing Prevalence of Genetic Disorders

The rise in genetic disorders globally is a key factor propelling the adoption of whole genome sequencing. Genetic conditions affect approximately 2-5% of live births, with a considerable global impact on childhood morbidity and mortality. With up to 80 million individuals estimated to be living with rare genetic disorders worldwide, the need for comprehensive diagnostic tools is escalating. WGS enables precise identification of genetic mutations, offering superior accuracy compared to traditional diagnostic methods. In countries like India, where nearly one million infants are born annually with genetic disorders-many undiagnosed-the use of WGS allows clinicians to detect conditions early and implement targeted treatments. This ability to provide early diagnosis, personalized care, and improved clinical outcomes positions WGS as a critical solution amid rising genetic health concerns.

Key Market Challenges

High Cost of Whole Genome Sequencing

Although sequencing costs have significantly declined, the overall expense associated with WGS remains a substantial barrier to widespread adoption, especially in low- and middle-income regions. While sequencing a genome can now be achieved for under $1,000, ancillary costs such as data analysis, storage, and advanced computational infrastructure add to the financial burden. Institutions must also invest in trained personnel to interpret complex genomic data. These cost-related challenges can limit access to WGS in smaller hospitals and research facilities, despite its long-term benefits in enhancing healthcare outcomes. This financial barrier continues to restrict the market's accessibility and full-scale integration into routine clinical practices.

Key Market Trends

Integration of Artificial Intelligence and Machine Learning in Genomic Data Analysis

A transformative trend in the WGS market is the growing use of artificial intelligence (AI) and machine learning (ML) for genomic data interpretation. The immense volume of data generated by WGS requires advanced analytics to extract meaningful insights. AI and ML technologies can identify complex patterns, predict mutation effects, and enhance the precision of personalized treatment strategies. These tools are revolutionizing clinical decision-making, enabling faster and more accurate diagnoses, supporting drug discovery, and optimizing research workflows. As AI-driven solutions continue to evolve, they will play a crucial role in scaling the utility of WGS across both clinical and research applications, enhancing efficiency and expanding its real-world impact.

Key Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Oxford Nanopore Technologies plc.
• Pacific Biosciences of California, Inc.
• BGI
• QIAGEN
• Agilent Technologies, Inc.
• ProPhase Labs, Inc.
• Psomagen, Inc
• Azenta US Inc.

Report Scope:

In this report, the Global Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Whole Genome Sequencing Market, By Product & Service:

• Instruments
• Consumables
• Services

Whole Genome Sequencing Market, By Type:

• Large Whole Genome Sequencing
• Small Whole Genome Sequencing

Whole Genome Sequencing Market, By Workflow:

• Pre-sequencing
• Sequencing
• Data Analysis

Whole Genome Sequencing Market, By Application:

• Human Whole Genome Sequencing
• Plant Whole Genome Sequencing
• Animal Whole Genome Sequencing
• Microbial Whole Genome Sequencing

Whole Genome Sequencing Market, By End User:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Whole Genome Sequencing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.

Available Customizations:

Global Whole Genome Sequencing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Whole Genome Sequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Service (Instruments, Consumables, Services)
  • 5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
  • 5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
  • 5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
  • 5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Whole Genome Sequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Workflow
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Whole Genome Sequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Workflow
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Whole Genome Sequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Workflow
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Whole Genome Sequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Workflow
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Whole Genome Sequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Workflow
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Whole Genome Sequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Workflow
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Whole Genome Sequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Workflow
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Whole Genome Sequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Workflow
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Whole Genome Sequencing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Workflow
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Whole Genome Sequencing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Workflow
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Whole Genome Sequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Workflow
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Whole Genome Sequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Workflow
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Whole Genome Sequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Workflow
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Whole Genome Sequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Workflow
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Whole Genome Sequencing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Workflow
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Whole Genome Sequencing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Workflow
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Whole Genome Sequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Workflow
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Whole Genome Sequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Workflow
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Whole Genome Sequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Workflow
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Whole Genome Sequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Workflow
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Whole Genome Sequencing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Workflow
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Whole Genome Sequencing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Workflow
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Workflow
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Whole Genome Sequencing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Workflow
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Whole Genome Sequencing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Illumina, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Thermo Fisher Scientific Inc.
• 14.3. Oxford Nanopore Technologies plc.
• 14.4. Pacific Biosciences of California, Inc.
• 14.5. BGI
• 14.6. QIAGEN
• 14.7. Agilent Technologies, Inc.
• 14.8. ProPhase Labs, Inc.
• 14.9. Psomagen, Inc
• 14.10.Azenta US Inc..

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료